American Century Companies Inc Assertio Holdings, Inc. Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.52 - $5.69 $435,113 - $982,458	-172,664 Reduced 22.6%	591,420 $1.51 Million
Q2 2023 Aug 14, 2023	BUY	$5.0 - $7.66 $578,170 - $885,756	115,634 Added 17.83%	764,084 $4.14 Million
Q1 2023 May 11, 2023	BUY	$3.54 - $6.66 $708,817 - $1.33 Million	200,231 Added 44.67%	648,450 $4.13 Million
Q4 2022 Feb 13, 2023	BUY	$2.11 - $4.3 $378,882 - $772,129	179,565 Added 66.84%	448,219 $1.93 Million
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $388,271 - $729,148	182,287 Added 211.06%	268,654 $610,000
Q2 2022 Aug 12, 2022	BUY	$1.88 - $3.42 $162,369 - $295,375	86,367 New	86,367 $255,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $44.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.